TransMedics Group Inc (NASDAQ:TMDX) — Market Cap & Net Worth
Market Cap & Net Worth: TransMedics Group Inc (TMDX)
TransMedics Group Inc (NASDAQ:TMDX) has a market capitalization of $2.91 Billion ($2.91 Billion) as of September 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #5029 globally and #1683 in its home market, demonstrating a -0.80% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying TransMedics Group Inc's stock price $87.56 by its total outstanding shares 34675145 (34.68 Million). Also see TransMedics Group Inc (TMDX) total assets for a full breakdown of the balance sheet.
TransMedics Group Inc Market Cap History: 2019 to 2026
TransMedics Group Inc's market capitalization history from 2019 to 2026. Data shows growth from $659.17 Million to $3.00 Billion (20.32% CAGR). Also see TMDX operating cash flow for how efficiently the company converts equity into cash flow.
Index Memberships
TransMedics Group Inc is a constituent of 3 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.66 Trillion | 0.11% | #133 of 976 |
|
NASDAQ Composite
IXIC
|
$41.69 Trillion | 0.01% | #564 of 3165 |
|
S&P Small-Cap 600 Index
SML
|
$1.61 Trillion | 0.23% | #213 of 602 |
Weight: TransMedics Group Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
TransMedics Group Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how TransMedics Group Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check today's stock price for TransMedics Group Inc for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
6.97x
TransMedics Group Inc's market cap is 6.97 times its annual revenue
Latest Price to Earnings (P/E) Ratio
22.17x
TransMedics Group Inc's market cap is 22.17 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $659.17 Million | $23.60 Million | -$33.55 Million | 27.93x | N/A |
| 2020 | $690.04 Million | $25.64 Million | -$28.75 Million | 26.91x | N/A |
| 2021 | $664.38 Million | $30.26 Million | -$44.22 Million | 21.95x | N/A |
| 2022 | $2.14 Billion | $93.46 Million | -$36.23 Million | 22.90x | N/A |
| 2023 | $2.74 Billion | $241.62 Million | -$25.03 Million | 11.33x | N/A |
| 2024 | $2.16 Billion | $441.54 Million | $35.46 Million | 4.90x | 60.96x |
| 2025 | $4.22 Billion | $605.49 Million | $190.29 Million | 6.97x | 22.17x |
Competitor Companies of TMDX by Market Capitalization
Companies near TransMedics Group Inc in the global market cap rankings as of September 18, 2026. Review TransMedics Group Inc tangible net worth ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to TransMedics Group Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #125 globally with a market cap of $177.99 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #228 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #229 globally with a market cap of $109.23 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #239 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #125 | Abbott Laboratories | NYSE:ABT | $177.99 Billion | $102.36 |
| #228 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $92.60 |
| #229 | Stryker Corporation | NYSE:SYK | $109.23 Billion | $284.76 |
| #239 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
TransMedics Group Inc Historical Marketcap From 2019 to 2026
Between 2019 and today, TransMedics Group Inc's market cap moved from $659.17 Million to $ 3.00 Billion, with a yearly change of 20.32%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $3.00 Billion | -28.76% |
| 2025 | $4.22 Billion | +95.11% |
| 2024 | $2.16 Billion | -21.01% |
| 2023 | $2.74 Billion | +27.88% |
| 2022 | $2.14 Billion | +222.13% |
| 2021 | $664.38 Million | -3.72% |
| 2020 | $690.04 Million | +4.68% |
| 2019 | $659.17 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 17th, 2026 the market cap of TransMedics Group Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.91 Billion USD |
| MoneyControl | $2.91 Billion USD |
| MarketWatch | $2.91 Billion USD |
| marketcap.company | $2.91 Billion USD |
| Reuters | $2.91 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About TransMedics Group Inc
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company provides Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic con… Read more